Characteristic | Variables | ||
N (%) | 95% CI | ||
Test subjects (n=296) | Animals | 5 (1.69) | — |
Humans | 189 (63.85) | — | |
Both | 0 (0) | — | |
Neither | 102 (34.46) | — | |
Country of journal publication (n=296) | USA | 130 (43.92) | — |
UK | 19 (6.42) | — | |
Australia | 16 (5.41) | — | |
Netherlands | 15 (5.07) | — | |
Germany | 15 (5.07) | — | |
Canada | 12 (4.05) | — | |
China | 11 (3.72) | — | |
Italy | 8 (2.7) | — | |
France | 6 (2.03) | — | |
Spain | 5 (1.69) | — | |
Portugal | 5 (1.69) | — | |
Israel | 5 (1.69) | — | |
Brazil | 5 (1.69) | — | |
Unclear | 3 (1.01) | — | |
Other | 41 (13.85) | — | |
Country of corresponding author (n=296) | USA | 155 (52.36) | — |
UK | 86 (29.05) | — | |
Netherlands | 32 (10.81) | — | |
Ireland | 8 (2.7) | — | |
Germany | 5 (1.69) | — | |
Switzerland | 3 (1.01) | — | |
France | 3 (1.01) | — | |
Canada | 1 (0.34) | — | |
Brazil | 1 (0.34) | — | |
Australia | 1 (0.34) | — | |
Unclear | 1 (0.34) | — | |
Open access (n=296) | Yes found via Open Access Button | 95 (32.1) | 26.8–37.4 |
Yes found article via other means | 12 (4.1) | 1.8–6.3 | |
Could not access through paywall | 189 (63.9) | 58.4–69.3 | |
5-year impact factor (n=296) | Median | 3.2 | — |
First quartile | 2.2 | — | |
Third quartile | 4.2 | — | |
IQR | 2.2–4.2 | — | |
Most recent impact factor year (n=296) | 2014 | 0 | — |
2015 | 0 | — | |
2016 | 0 | — | |
2017 | 270 | — | |
2018 | 0 | — | |
Other | 30 | — | |
Most recent impact factor (n=296) | Median | 3 | — |
First quartile | 1.9 | — | |
Third quartile | 4 | — | |
IQR | 1.9–4.0 | — |